openPR Logo
Press release

A complete guide to Adoptive Cell Therapy Market 2023: growing demand for personalized medicine rapid growth | Gilead Sciences, Inc., Castle Creek Biosciences, Inc., Lineage Cell Therapeutics

03-17-2023 07:59 AM CET | Health & Medicine

Press release from: CMI Research

Adoptive Cell Therapy Market

Adoptive Cell Therapy Market

Adoptive cell therapy (ACT) is a form of immunotherapy that involves the genetic modification of T cells to enhance their cancer-fighting capabilities. This treatment has shown promising results in the treatment of several types of cancer and is expected to become a major player in the oncology market in the coming years.

The global adoptive cell therapy market size was valued at USD 1.12 billion in 2021 and is projected to reach USD 9.73 billion by 2028, growing at a CAGR of 32.7% from 2023 to 2028. The increasing prevalence of cancer and the growing demand for personalized medicine are the key drivers of this market.

Click Here to Request a Sample PDF Copy with More Details:
https://www.coherentmarketinsights.com/insight/request-sample/4957

TIL therapy involves isolating T cells from a patient's tumor and expanding them in a lab. These T cells are then infused back into the patient's body, where they can recognize and attack cancer cells.

CAR T-cell therapy involves modifying a patient's T cells to express a chimeric antigen receptor (CAR) that targets a specific cancer antigen. Once infused back into the patient's body, these CAR T cells can recognize and attack cancer cells.

TCR therapy involves modifying a patient's T cells to express a T cell receptor (TCR) that targets a specific cancer antigen. These modified T cells are then infused back into the patient's body to recognize and attack cancer cells.

Some of the prominent players reviewed in the research report include:

✤ Novartis AG.
✤ Gilead Sciences, Inc.
✤ Castle Creek Biosciences, Inc
✤ Lineage Cell Therapeutics, Inc.
✤ Transgene SA
✤ Cellectis
✤ ImmunityBio, Inc
✤ Sorrento Therapeutics
✤ bluebird bio, Inc.
✤ Arcellx
✤ Sana Biotechnology, Inc.
✤ Biodesix, Inc
✤ Laurus Labs

The global incidence of cancer is increasing, with an estimated 19.3 million new cases and 10 million cancer-related deaths reported in 2020. This is driving the demand for new and effective cancer treatments, including adoptive cell therapy.

Personalized medicine, which involves tailoring treatment to an individual's genetic profile, is gaining popularity. Adoptive cell therapy is a personalized treatment that can be customized to target a patient's specific cancer antigens.

The development of gene editing technologies, such as CRISPR/Cas9, has made it easier to modify T cells to express CARs or TCRs. This has led to more efficient and effective adoptive cell therapies.

Segment By Type:

✤ CAR-T
✤ TCR-T
✤ NK
✤ TIL

Segment By Application:

✤ Lymphoma
✤ Leukemia
✤ Others

Report Scope

This report aims to provide a comprehensive presentation of the global market for Adoptive Cell Therapy , with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adoptive Cell Therapy .

The Adoptive Cell Therapy market size, estimations, and forecasts are provided in terms of sales volume and revenue, considering 2030 as the base year, with history and forecast data for the period from 2023 to 2030. This report segments the global Adoptive Cell Therapy market comprehensively. Regional market sizes, concerning products by types, application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The report will help the Adoptive Cell Therapy manufacturers, new entrants, and industry chain-related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Limited Period Offer | UP TO 45% Discount on Research Report @

Single User License : https://www.coherentmarketinsights.com/promo/buynow/4957

Multi Users License : https://www.coherentmarketinsights.com/promo/buynow/4957

Corporate Users License : https://www.coherentmarketinsights.com/promo/buynow/4957

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2023-2030. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Global Adoptive Cell Therapy Market: Regional Segmentation

For a deeper understanding, the research report includes geographical segmentation of the global Adoptive Cell Therapy market. It provides an evaluation of the volatility of the political scenarios and amends likely to be made to the regulatory structures. This assessment gives an accurate analysis of the regional-wise growth of the global Adoptive Cell Therapy market.

The Middle East and Africa (GCC Countries and Egypt)
North America (the United States, Mexico, and Canada)
South America (Brazil etc.)
Europe (Turkey, Germany, Russia UK, Italy, France, etc.)
Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)

Adoptive Cell Therapy Market Most Critical Questions

1)What is the market size of the Adoptive Cell Therapy market at the global level?
2) Which screen size is most preferred by the consumers of Adoptive Cell Therapy ?
3) Which mode of distribution channel is most preferred by the manufacturers?
4) Which is the preferred age group for targeting Adoptive Cell Therapy for manufacturers?
5) What the key factors driving, inhibiting the growth of the market, and what is the degree of impact of the drivers and restraints?
6) What is the impact of the regulations on the growth of the Adoptive Cell Therapy market?
7) Which is the leading region/country for the market's growth? What is the anticipated growth rate of the leading regions during the forecast period?
8) How are the emerging markets for Adoptive Cell Therapy expected to perform in the coming years? How is the consumption pattern expected to evolve in the future?
9) Who are the major players operating in the global Adoptive Cell Therapy market? What is the current market position of the key players? Who are the emerging players in this industry?

Request PDF Brochure with Latest Insights:
https://www.coherentmarketinsights.com/insight/request-sample/4957

Some of the Points covered in the Global Adoptive Cell Therapy Market Research Report are:

Chapter 1: Overview of the Global Adoptive Cell Therapy Market

• Definition
• Specifications
• Classification
• Applications
• Regions

Chapter 2: Market Competition by Players/Suppliers

• Manufacturing Cost Structure
• Raw Material and Suppliers
• Manufacturing Process
• Industry Chain Structure

Chapter 3: Sales (Volume) and Revenue (Value) by Region

• Sales
• Revenue and market share

Chapter 4, 5, and 6: Global Adoptive Cell Therapy Market by Type, Application & Players/Suppliers Profiles
• Market Share by Type & Application
• Growth Rate by Type & Application
• Drivers and Opportunities
• Company Basic Information

Continued………….

Limited Period Offer | UP TO 45% Discount on Research Report @ https://www.coherentmarketinsights.com/promo/buynow/4957

Finally, the report Adoptive Cell Therapy Market provides an industry development game plan, the industry information source, research findings, an appendix, and a conclusion. The report offers precise clarification of the market by highlighting the market manufacturing procedure, market competitors, sellers, and merchants' classification, the implementation of innovation, and business improvement designs. All these details will reassure clients of future plans and actions intended to compete with other players in the market. Further, the most recent improvements in the market are displayed.

Contact Us :

Mr. Shah

Coherent Market Insights
533 Airport Boulevard, Suite 400,
Burlingame, CA 94010, United States.
📞 U.S.A: +1-206-701-6702
📞 UK: +44-020-8133-4027
📞 JAPAN: +050-5539-1737
📞 India: +91-848-285-0837
✉ Email: sales@coherentmarketinsights.com
🌐 Website: https://www.coherentmarketinsights.com/

About Us:

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed to playing a leading role in offering insights into various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release A complete guide to Adoptive Cell Therapy Market 2023: growing demand for personalized medicine rapid growth | Gilead Sciences, Inc., Castle Creek Biosciences, Inc., Lineage Cell Therapeutics here

News-ID: 2979320 • Views:

More Releases from CMI Research

Complete guide to Eosinophilic Esophagitis Market 2023: Expanding due to immune system rapid growth | Ellodi Pharmaceuticals, EsoCap AG, GlaxoSmithKline
Complete guide to Eosinophilic Esophagitis Market 2023: Expanding due to immune …
Eosinophilic Esophagitis (EoE) is a chronic inflammatory condition of the esophagus. It is characterized by the accumulation of a type of white blood cells called eosinophils in the lining of the esophagus. EoE can cause a range of symptoms, including difficulty swallowing, food impaction, chest pain, and heartburn. Steroids are the primary treatment option for EoE. They help control inflammation and reduce the number of eosinophils in the esophagus. Topical steroids
A complete guide to the TCV Vaccines Market 2023: market size, growth trends, key drivers and and future outlook 2030 | GlaxoSmithKline PLC, Sanofi SA, Bharat Biotech
A complete guide to the TCV Vaccines Market 2023: market size, growth trends, ke …
Conjugate vaccine (Vi-TT) consists of Vi antigen that is coupled to a carrier protein. In this vaccine, polysaccharide is attached to a more complex protein. In infants, these cells can effectively develop immune protection against pathogens. Polysaccharides are weaker by itself, however, by binding to a protein carrier, polysaccharides can enter into important parts of the immune system with ease and can get more easily noticed by the immunity system
A complete guide to Corporate Wellness Market 2023: Market size, growth trends, key drivers and challenges, and future outlook 2030 | Wellness Corporate Solutions, ComPsych Corporation, United Health Group
A complete guide to Corporate Wellness Market 2023: Market size, growth trends, …
The corporate wellness market has been gaining popularity over the years as more companies recognize the importance of keeping their employees healthy and productive. Corporate wellness programs are designed to improve the overall health and well-being of employees by providing them with resources and support to manage their physical and mental health. The corporate wellness market is expected to grow significantly from 2023-2030. According to a report by Coherent Market Insights,
Ticagrelor Market is expected to grow from 2023 to 2030 | C.H. Boehringer Sohn AG & Ko. KG, Eli Lilly and Company, AstraZeneca plc
Ticagrelor Market is expected to grow from 2023 to 2030 | C.H. Boehringer Sohn A …
Ticagrelor is an antiplatelet medication that helps prevent blood clots by making blood flow more easily through veins. It is commonly used to reduce the risk of cardiovascular events, such as heart attack or stroke, in patients with acute coronary syndrome (ACS) or a history of myocardial infarction (MI). Ticagrelor works by inhibiting the P2Y12 receptor on platelets, which reduces their ability to stick together and form clots. The medication is

All 5 Releases


More Releases for Adoptive

Adoptive Cell Therapy Market Recent Trends, Future Growth, High Demand and Forec …
The new report by Market Research Inc. titled, Global Adoptive Cell Therapy Market Report and Forecast 2022-2030', gives a top to bottom analysis of the global Adoptive Cell Therapy Market, evaluating the market based on its segments like types, distribution channels, processes, applications, and regions. The report tracks the most recent trends in the industry and studies their effect on the overall market. It also evaluates the market dynamics, covering
Adoptive cell therapy for cancer treatment Market Analysis 2017-2027: By Market …
Adoptive T Cell Therapy referred as lymphocyte transfusion, which is being tested for the cancer treatment and chronic infections. Adoptive T Cell Therapy can increase the Anti-tumor immunity, enhance vaccine efficacy, etc. There is three basic treatment for curing cancer: surgery, chemotherapy, and radiotherapy. The new technique or therapy, i.e., adoptive T cell therapy emerged as a fourth therapy for the cancer treatment. Because adoptive T cell therapy targeting cancer
Adoptive cell therapy for cancer treatment Market Sales and Market Shares of Maj …
"Adoptive cell therapy for cancer treatment Market: Global Industry Analysis and Opportunity Assessment 2017-2027" The main objective of this report is to aid the user in understanding the market “ ” as a whole, its definitions, segmentation, market potential, influential trends, and the barriers that it is facing. Meticulous research and analysis were an important part of the report preparation. Those reading the report will be able to get a detailed
Adoptive cell therapy for cancer treatment Market Poised for Steady Growth in th …
Adoptive T Cell Therapy referred as lymphocyte transfusion, which is being tested for the cancer treatment and chronic infections. Adoptive T Cell Therapy can increase the Anti-tumor immunity, enhance vaccine efficacy, etc. There is three basic treatment for curing cancer: surgery, chemotherapy, and radiotherapy. The new technique or therapy, i.e., adoptive T cell therapy emerged as a fourth therapy for the cancer treatment. Because adoptive T cell therapy targeting cancer
Adoptive cell therapy for cancer treatment Market Poised to Expand at a Robust P …
Adoptive T Cell Therapy referred as lymphocyte transfusion, which is being tested for the cancer treatment and chronic infections. Adoptive T Cell Therapy can increase the Anti-tumor immunity, enhance vaccine efficacy, etc. There is three basic treatment for curing cancer: surgery, chemotherapy, and radiotherapy. The new technique or therapy, i.e., adoptive T cell therapy emerged as a fourth therapy for the cancer treatment. Because adoptive T cell therapy targeting cancer
Adoptive cell therapy for cancer treatment Market Segments, Growth and Value Cha …
Adoptive T Cell Therapy referred as lymphocyte transfusion, which is being tested for the cancer treatment and chronic infections. Adoptive T Cell Therapy can increase the Anti-tumor immunity, enhance vaccine efficacy, etc. There is three basic treatment for curing cancer: surgery, chemotherapy, and radiotherapy. The new technique or therapy, i.e., adoptive T cell therapy emerged as a fourth therapy for the cancer treatment. Because adoptive T cell therapy targeting cancer